Benjamin R. Yerxa, EVP & Chf, Research & Develop at INSPIRE PHARMACEUTICALS INC (ISPH), sold 2,000 shares at $6.79 ($13K) on 2010-05-03, disclosed to the SEC on 2010-05-05.
Scheduled sale ($13k) by EVP & Chf, Research & Develop under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.69 | 429 | $3K | 21.3% |
| 2 | $6.70 | 571 | $4K | 28.4% |
| 3 | $6.75 | 200 | $1K | 10.0% |
| 4 | $6.76 | 100 | $676 | 5.0% |
| 5 | $6.77 | 300 | $2K | 15.1% |
| 6 | $6.78 | 161 |
| $1K |
| 8.1% |
| 7 | $6.79 | 39 | $265 | 2.0% |
| 8 | $6.80 | 100 | $680 | 5.0% |
| 9 | $6.82 | 100 | $682 | 5.1% |
| Total | $6.74 avg | 2,000 | $13K | 100% |
| Filing → |
| IRD | BUY | 2024-11-25 | $10K | — | Filing → |
| CLSD | BUY | 2024-05-15 | $10K | — | Filing → |
| ISPH | SELL | 2010-04-05 | $13K | — | Filing → |